NCT03551444 Recurrence Rate of Hepatocellular Carcinoma After Treatment of Chronic Hepatits C Patients With Direct Acting Antivirals: Randomized Controlled Phase 3 Trial Status UNKNOWN Phase PHASE3
NCT03539822 Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies Status RECRUITING Phase PHASE1/PHASE2
NCT03538028 A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies Status COMPLETED Phase PHASE1
NCT03534141 Mild Hypothermia and Acute Kidney Injury in Liver Transplantation Status TERMINATED Phase NA
NCT03520257 The Study of Apatinib Plus Radiotherapy vs. Apatinib in the Treatment of Hepatocellular Carcinoma With BCLC-C Stage I and Stage II Portal Vein Tumor Thrombus Status UNKNOWN Phase PHASE2
NCT03519997 A Study of Pembrolizumab and Bavituximab in Patients With Advanced Hepatocellular Carcinoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03518502 Sorafenib Monotherapy vs. TACE-sorafenib Sequential Therapy for HCC With Metastasis Status UNKNOWN Phase PHASE4
NCT03517488 A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT03515369 Effect of Babaodan on Tumor Recurrence After Curative Resection of Hepatocellular Carcinoma Status UNKNOWN Phase PHASE4
NCT03511703 The Study of The Treatment of Postoperative Adjuvant Apatinib vs. TACE in Hepatocellular Carcinoma Patients Status UNKNOWN Phase PHASE2
NCT03511222 Vorolanib (X-82) Combined With Checkpoint Inhibitors in Patients With Solid Tumors Status TERMINATED Phase PHASE1
NCT03507998 Phase 1 Dose Escalation Study of CGX1321 in Subjects With Advanced Gastrointestinal Tumors Status UNKNOWN Phase PHASE1
NCT03493763 Study on Recurrence Monitoring of Hepatocellular Carcinoma With 5-Hydroxymethylcytosine Test Status UNKNOWN Phase N/A
NCT03490461 Effects of Statin on Hepatocellular Carcinoma Recurrence After Liver Transplantation Status COMPLETED Phase N/A